Portland, OR -- (SBWIRE) -- 09/20/2017 -- Professional diagnostics are referred to those diagnostic methods that provide faster detection of diseases such as cancer, malaria, infections, blood glucose levels and others in an individual. The sole objective of the professional tests is to provide early diagnosis and hence an early treatment and have successfully replaced many laboratory and clinical experiments. The key factors that drive the market growth are increasing focus towards early diagnosis of chronic diseases such as cancer, malaria, among many others. In addition, rising need of early diagnosis of sepsis and acute cardiac infarction, boosts the demand for point of care tests (POCT) further fuelling the market growth. However, industry consolidation posing threat to new entrants along with dearth of skilled professionals restraints the market growth. Moreover, increasing technological developments in the field of professional diagnostics will offer lucrative opportunities for the market growth.
Access the full summary at: https://www.alliedmarketresearch.com/professional-diagnostics-market
Get PDF Brochure of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/3789
The key players of the market are F. Hoffman-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Thermo Fischer Scientific Inc., Siemens Medical Solutions USA, Inc., Abaxis, Hologenic Inc., Bio-Rad Laboratories Inc., Becton, Dickenson and Company (BD), Alere and Enzo Biochem Inc.
-The study provides an in-depth analysis of the global professional diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets.
-Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
-Comprehensive quantitative analysis of the industry is provided for the period of 20162023 to assists stakeholders to capitalize on the prevailing market opportunities.
Early buyers will receive 20% customization on this report